Showing results (21-30 of 45) with videos related to
Sort By:
Pageof 5
Journal of Magnetic Resonance Imaging : JMRI|August 10, 2017
Quantitative susceptibility mapping as a monitoring biomarker in cerebral cavernous malformations with recent hemorrhageHussein A Zeineddine, Romuald Girard, Ying Cao, et al.Neurosurgery|April 13, 2017
Surgical Performance in Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation Phase III Clinical TrialMaged D Fam, Daniel Hanley, Agnieszka Stadnik, et al.Neurosurgery|January 31, 2015
Bleeding and infection with external ventricular drainage: a systematic review in comparison with adjudicated adverse events in the ongoing Clot Lysis Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III (CLEAR-III IHV) trialMahua Dey, Agnieszka Stadnik, Fady Riad, et al.Neurosurgery|April 17, 2018
Trial Readiness in Cavernous Angiomas With Symptomatic Hemorrhage (CASH)Sean P Polster, Ying Cao, Timothy Carroll, et al.Stroke|August 27, 2011
Low-dose recombinant tissue-type plasminogen activator enhances clot resolution in brain hemorrhage: the intraventricular hemorrhage thrombolysis trialNeal Naff, Michael A Williams, Penelope M Keyl, et al.Medicine|June 19, 2023
Losartan in hospitalized patients with COVID-19 in North America: An individual participant data meta-analysisLeon Di Stefano, Malathi Ram, Daniel O Scharfstein, et al.International Journal of Stroke : Official Journal of the International Stroke Society|September 17, 2013
A multicenter, randomized, double-blinded, placebo-controlled phase III study of Clot Lysis Evaluation of Accelerated Resolution of Intraventricular Hemorrhage (CLEAR III)Wendy C Ziai, Stanley Tuhrim, Karen Lane, et al.Journal of the American Heart Association|January 16, 2024
Rationale and Design of the mTECH-Rehab Randomized Controlled Trial: Impact of a Mobile Technology Enabled Corrie Cardiac Rehabilitation Program on Functional Status and Cardiovascular HealthNino Isakadze, Chang H Kim, Francoise A Marvel, et al.The Lancet. Neurology|March 22, 2025
Safety and efficacy of atorvastatin for rebleeding in cerebral cavernous malformations (AT CASH EPOC): a phase 1/2a, randomised placebo-controlled trialIssam A Awad, Roberto J Alcazar-Felix, Agnieszka Stadnik, et al.Journal of Clinical and Translational Science|January 17, 2024
Development, implementation, and dissemination of operational innovations across the trial innovation networkMarisha E Palm, Terri L Edwards, Cortney Wieber, et al.Pageof 5